BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by dateSort by citations
Year Range
to
Clear all filters

All Papers

31+ results
Field: Pneumocystis jirovecii pneumonia detection and treatment

Sophorolipid exhibits antifungal activity by ROS mediated endoplasmic reticulum stress and mitochondrial dysfunction pathways in <i>Candida albicans</i>

Verified

Farazul Haque, Nitish Kumar Verma, Mohammad Alfatah, Swati Bijlani et al.

Journal: RSC Advances
Year: 2019
Citations: 63

Sophorolipid induces ROS generation in <italic>C. albicans</italic> leading to mitochondrial dysfunction and ER stress followed by the release of Ca<sup>2+</sup> ions (from the ER lumen) that enter mitochondria and further magnify ROS generation leading to cell death.

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation

Verified

Sultan Ahmed, Rubhana Raqib, Guðmundur H. Guðmundsson, Peter Bergman et al.

Journal: AntibioticsYear: 2020Citations: 61

Tuberculosis (TB) is one of the leading causes of mortality and morbidity, particularly in developing countries, presenting a major threat to the public health. The currently recommended long term treatment regimen with multiple antibiotics is associated with poor patient compliance, which in turn, ...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project

Verified

Maria Deloria Knoll, Julia C. Bennett, Maria Garcia Quesada, E. Wangeci Kagucia et al.

Journal: MicroorganismsYear: 2021Citations: 60

Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13). The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project aimed to evaluate the global evidence to...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

A <i>Streptococcus pneumoniae</i> Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease

Verified

Madhu Emmadi, Naeem Khan, Lennart Lykke, Katrin Reppe et al.

Journal: Journal of the American Chemical SocietyYear: 2017Citations: 60

Invasive pneumococcal diseases (IPDs) remain the leading cause of vaccine-preventable childhood death, even though highly effective pneumococcal conjugate vaccines (PCVs) are used in national immunization programs in many developing countries. Licensed PCVs currently cover only 13 of the over 90 ser...

Health SciencesMedicineEpidemiology
Read Source

Pulmonary Mononuclear Cell Responses to Antigens of <i>Mycobacterium tuberculosis</i> in Healthy Household Contacts of Patients with Active Tuberculosis and Healthy Controls from the Community

Verified

Stephan Schwander, Martha Torres, Claudia Carranza C, Dante Escobedo et al.

Journal: The Journal of ImmunologyYear: 2000Citations: 60

Protective immunity against Mycobacterium tuberculosis requires CD4+ lymphocyte-mediated immune responses and IFN-gamma activity. As the primary portal of entry of M. tuberculosis is the lung, pulmonary immune responses against multiple M. tuberculosis Ags were compared between both M. tuberculosis-...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Distribution of Serotypes, Vaccine Coverage, and Antimicrobial Susceptibility Pattern of Streptococcus Pneumoniae in Children Living in SAARC Countries: A Systematic Review

Verified

Nishant Jaiswal, Meenu Singh, Rashmi Ranjan Das, Ishita Jindal et al.

Journal: PLoS ONEYear: 2014Citations: 57

INTRODUCTION: Each SAARC nation falls in the zone of high incidence of pneumococcal disease but there is a paucity of literature estimating the burden of pneumococcal disease in this region. OBJECTIVE: To identify the prevalent serotypes causing invasive pneumococcal disease in children of SAARC cou...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

Role of different tautomers in the base-pairing abilities of some of the vital antiviral drugs used against COVID-19

Verified

N. R. Jena

Journal: Physical Chemistry Chemical PhysicsYear: 2020Citations: 53

Repurposed drugs are now considered as attractive therapeutics against COVID-19. It is shown that Remdesivir, a nucleoside drug that was originally invented for the Ebola virus, is effective in suppressing the replication of SARS-CoV-2 that causes COVID-19. Similarly, Galidesivir, Favipiravir, Ribav...

Health SciencesMedicineInfectious Diseases
Read Source

Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings

Verified

Giovanni Sotgiu, Simon Tiberi, Rosella Centis, Lia D’Ambrosio et al.

Journal: International Journal of Infectious DiseasesYear: 2016Citations: 49

In spite of the recent introduction of two new drugs (delamanid and bedaquiline) and a few repurposed compounds to treat multidrug-resistant and extensively drug-resistant tuberculosis (MDR- and XDR-TB), clinicians are facing increasing problems in designing effective regimens in severe cases. Recen...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Risk factors of multi-drug-resistant tuberculosis in Bangladeshi population: a case control study

Verified

M S Flora, MN Amin, MR Karim, Shahana Afroz et al.

Journal: Bangladesh Medical Research Council BulletinYear: 2013Citations: 49

Despite success in tuberculosis control, multi-drug resistant tuberculosis in Bangladesh is increasing and currently multi-drug-resistant tuberculosis rate is 3.6% in new cases and 19% in re-treatment cases. This study focused on determination of multi-drug-resistant tuberculosis which is warranted ...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Prevalence of sputum smear-positive tuberculosis in a rural area in Bangladesh

Verified

Khalequz Zaman, Mohammad Yunus, Shams El Arifeen, Abdullah H Baqui et al.

Journal: Epidemiology and InfectionYear: 2006Citations: 49

The objective of the study was to determine the prevalence of smear-positive tuberculosis (TB) in a rural area in Bangladesh at Matlab. A TB surveillance system was established among 106,000 people in rural Bangladesh at Matlab. Trained field workers interviewed all persons aged > or = 15 years to d...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort

Verified

S Koirala, Borisov Se, Edvardas Danila, Andrei Mariandyshev et al.

Journal: PulmonologyYear: 2021Citations: 47

The World Health Organization (WHO) recommends countries introduce new anti-TB drugs in the treatment of multidrug-resistant tuberculosis. The aim of the study is to prospectively evaluate the effectiveness of bedaquiline (and/or delamanid)- containing regimens in a large cohort of consecutive TB pa...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

The lipopolysaccharide of <i>Moraxella catarrhalis</i>

Verified

Tord Holme, Motiur Rahman, Per‐Erik Jansson, Göran Widmalm

Journal: European Journal of BiochemistryYear: 1999Citations: 47

Moraxella catarrhalis has recently been shown to be both widespread and pathogenic, in contrast to previous reports. Several factors have been suggested as virulence factors, lipopolysaccharide (LPS) being one. Recent studies have shown the LPS to be without the O-chain, i.e. the polysaccharide part...

Health SciencesMedicineEpidemiology
Read Source

Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now

Verified

Kona Chowdhury, Rahnuma Ahmad, Susmita Sinha, Siddhartha Dutta et al.

Journal: CureusYear: 2023Citations: 46

Drug-resistant tuberculosis (DR-TB) has continued to be a global health cataclysm. It is an arduous condition to tackle but is curable with the proper choice of drug and adherence to the drug therapy. WHO has introduced newer drugs with all-oral shorter regimens, but the COVID-19 pandemic has disrup...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence

Verified

Arnaud Trébucq, Tom Decroo, Armand Van Deun, Alberto Piubello et al.

Journal: Journal of Clinical MedicineYear: 2019Citations: 45

About ten years ago, the first results of the so-called "Bangladesh regimen", a short regimen lasting nine months instead of 20 months, revolutionized multidrug-resistant tuberculosis (MDR-TB) treatment. Similar short regimens were studied in different settings, relying for their efficacy on a later...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

HIV gp120 in the Lungs of Antiretroviral Therapy–treated Individuals Impairs Alveolar Macrophage Responses to Pneumococci

Verified

Paul Collini, Martin A. Bewley, M. Mohasin, Helen M. Marriott et al.

Journal: American Journal of Respiratory and Critical Care MedicineYear: 2018Citations: 45

Abstract Rationale People living with HIV are at significantly increased risk of invasive pneumococcal disease, despite long-term antiretroviral therapy (ART). The mechanism explaining this observation remains undefined. Objectives To determine if apoptosis-associated microbicidal mechanisms, requir...

Health SciencesMedicineEpidemiologyOpen Access
Read Source
PreviousPage 2 of 3+Next